ArticlePharmacoEconomics2006

Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.

Nick Bosanquet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.